UNOMR (Grant)
Funding Details
Awarder
Inbox
Date Award
May 17, 2025
Vertical
Techbio / Proteomics
Funding Amount
$165,000
Company Info
Traction
The startup aims to capture up to 50% of the global protein characterization market worth USD 21bn, with an annual growth rate of 16%. It works with customers in life science R&D, clinical & diagnostic, and food & beverage sectors.
Founders
Dr. Til Schlotter, Dr. Julian Hengsteler, Dr. Julia Wagner
Market
Healthcare, Pharmaceutical R&D, Food Science
Location
Switzerland
Company Description

ETH techbio spin-off UNOMR is developing a novel single-molecule protein analysis technology to address limitations in current proteomics tools. The company aims to make high-resolution protein modification analysis broadly accessible across healthcare, pharmaceutical R&D, and food science.

Links